84
Participants
Start Date
August 15, 2025
Primary Completion Date
April 15, 2027
Study Completion Date
April 15, 2028
Intradermal Microdialysis
A total of three microdialysis sites will be perfused with ringer's solution, L-NAME, or ketorolac (one drug per site). After a baseline period, all three sites will undergo tests of blood vessel function including an acetylcholine dose-response protocol and a test of maximal skin blood flow with sodium nitroprusside.
Brain Blood Flow Tests
Participants will complete CO2 breathing procedures to evaluate brain blood vessel health.
Local Heating
A dime-sized heater will be placed on the skin to evaluate cutaneous microvascular function
Anna Stanhewicz, PhD
OTHER